AAH21192.1
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Septin 9
NCBI Official Synonym Full Names
septin 9
NCBI Official Synonym Symbols
MSF; MSF1; NAPB; SINT1; PNUTL4; SeptD1; AF17q25 [Similar Products]
NCBI Protein Information
septin-9; septin D1; Ov/Br septin; ovarian/breast septin; MLL septin-like fusion protein MSF-A
UniProt Protein Name
Septin-9
UniProt Synonym Protein Names
MLL septin-like fusion protein MSF-A; MLL septin-like fusion protein; Ovarian/Breast septin; Ov/Br septin; Septin D1
UniProt Synonym Gene Names
UniProt Entry Name
SEPT9_HUMAN
NCBI Summary for SEPT9
This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2009]
UniProt Comments for SEPT9
SEPT9: a member of a family of novel GTP binding proteins that have been implicated in cytokinesis and exocytosis. This family include the cell division control proteins CDC3, CDC10, CDC11. Required for the completion of cytokinesis and suggest a role that is distinct from that of Nedd5.
Protein type: Hydrolase; Cell cycle regulation; Cytoskeletal
Chromosomal Location of Human Ortholog: 17q25
Cellular Component: microtubule; perinuclear region of cytoplasm; cytoplasm; stress fiber; actin cytoskeleton
Molecular Function: GTPase activity; protein binding; GTP binding
Biological Process: cell division; protein heterooligomerization; metabolic process; cell cycle
Disease: Amyotrophy, Hereditary Neuralgic
Research Articles on SEPT9
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Pathways associated with anti-SEPT9 antibody
Diseases associated with anti-SEPT9 antibody
Disease Name |
Pubmed Publications |
Nervous System Diseases Antibodies |
>23 publications with SEPT9 and Nervous System Diseases |
Brachial Plexus Neuritis Antibodies |
>17 publications with SEPT9 and Brachial Plexus Neuritis |
Carcinoma Antibodies |
>14 publications with SEPT9 and Carcinoma |
Leukemia, Myeloid, Acute Antibodies |
>14 publications with SEPT9 and Leukemia, Myeloid, Acute |
Cell Transformation, Neoplastic Antibodies |
>9 publications with SEPT9 and Cell Transformation, Neoplastic |
Carcinoma, Squamous Cell Antibodies |
>7 publications with SEPT9 and Carcinoma, Squamous Cell |
Disease Models, Animal Antibodies |
>4 publications with SEPT9 and Disease Models, Animal |
Neoplasms, Experimental Antibodies |
>3 publications with SEPT9 and Neoplasms, Experimental |
Precancerous Conditions Antibodies |
>3 publications with SEPT9 and Precancerous Conditions |
Kidney Neoplasms Antibodies |
>3 publications with SEPT9 and Kidney Neoplasms |
Organs/Tissues associated with anti-SEPT9 antibody
|